Clinico-Microbiological Profile of Carbapenem-Resistant Acinetobacter baumannii Isolates From Intensive Care Unit Patients and In Vitro Activity of Sulbactam-Durlobactam: A Cross-Sectional Study From Eastern India

Cureus. 2026 Feb 24;18(2):e104172. doi: 10.7759/cureus.104172. eCollection 2026 Feb.ABSTRACTBackground Carbapenem-resistant Acinetobacter baumannii (CRAB) causes severe infections in intensive care units (ICUs), with increased morbidity and mortality. The pathogen exhibits extensive antimicrobial re

What is the Target Resting Heart Rate in Guidelines on Hypertension?

Curr Hypertens Rev. 2026 Mar 24. doi: 10.2174/0115734021424078251219091427. Online ahead of print.ABSTRACTIt is widely recognized that not only high blood pressure (BP) but also increased resting heart rate (RHR) impairs prognosis in patients with arterial hypertension (HTN). This study aims to answ

The Turkish Hypertension Consensus Report 2025

Turk Kardiyol Dern Ars. 2026 Feb 27. doi: 10.5543/tkda.2026.23791. Online ahead of print.ABSTRACTThe Turkish Hypertension Consensus Report (THCR) was first published in 2015 and subsequently updated in 2019 to provide practical guidance for clinicians involved in the diagnosis and management of hype

PVRI-GoDeep-A Global Meta-Registry at the Crossroads of Heart and Lung

Compr Physiol. 2026 Apr;16(2):e70118. doi: 10.1002/cph4.70118.ABSTRACTPulmonary hypertension (PH) is a complex disease characterized by increased pressure in the pulmonary arteries. It encompasses a heterogeneous group of entities that increase right heart afterload and often lead to right heart fai

2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension League

J Hypertens. 2026 Mar 17. doi: 10.1097/HJH.0000000000004290. Online ahead of print.ABSTRACTHypertension is the main risk factor for cardiovascular disease (CVD), affecting 20-40% of Latin American (LATAM) adults, and responsible for more than two million deaths annually due to CVD. The different eth